Edward White

Stock Analyst at HC Wainwright & Co.

(1.69)
# 3,197
Out of 4,884 analysts
372
Total ratings
25.79%
Success rate
n/a
Average return

Stocks Rated by Edward White

Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $7.75
Upside: +325.81%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $5.81
Upside: +192.60%
Inozyme Pharma
Apr 10, 2025
Reiterates: Buy
Price Target: $16
Current: $4.00
Upside: +300.00%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $7.70
Upside: +94.81%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $1.77
Upside: +238.98%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20$16
Current: $1.75
Upside: +814.29%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.85
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $9.27
Upside: +763.46%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.46
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $1.59
Upside: +1,157.86%
Reiterates: Neutral
Price Target: n/a
Current: $5.91
Upside: -
Maintains: Buy
Price Target: $15$16
Current: $3.11
Upside: +414.47%
Maintains: Buy
Price Target: $22$25
Current: $6.47
Upside: +286.40%
Reiterates: Buy
Price Target: $8
Current: $0.81
Upside: +886.44%
Reiterates: Neutral
Price Target: n/a
Current: $4.94
Upside: -
Reiterates: Neutral
Price Target: n/a
Current: $0.61
Upside: -
Reiterates: Buy
Price Target: $55
Current: $36.29
Upside: +51.56%
Reiterates: Buy
Price Target: $51
Current: $9.00
Upside: +466.67%
Reiterates: Buy
Price Target: $7
Current: $3.57
Upside: +96.08%
Maintains: Buy
Price Target: $7$56
Current: $4.66
Upside: +1,101.72%
Reiterates: Buy
Price Target: $31
Current: $10.15
Upside: +205.42%
Initiates: Neutral
Price Target: n/a
Current: $1.14
Upside: -
Initiates: Buy
Price Target: $28
Current: $0.28
Upside: +9,910.73%
Maintains: Buy
Price Target: $34$30
Current: $21.93
Upside: +36.80%
Downgrades: Neutral
Price Target: $12
Current: $1.12
Upside: +971.43%